Anti-PGLYRP2 antibodies are used in the immunodetection of the protein peptidoglycan recognition protein 2. In humans, the canonical protein has a reported length of 576 amino acid residues and a mass of 62.2 kDa. It has been described to be a secreted protein. Up to 2 different isoforms have been reported for this protein. It is reported to be highly expressed in the liver and fetal liver, and secreted into serum. A member of the N-acetylmuramoyl-L-alanine amidase 2 protein family, PGLYRP2 is believed to play a scavenger role by digesting biologically active peptidoglycan (PGN) into biologically inactive fragments. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include peptidoglycan recognition protein L, peptidoglycan recognition protein long, and N-acetylmuramoyl-L-alanine amidase. PGLYRP2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Some PGLYRP2 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.